Market Access
Solution Spotlight: Acumetis Model Builder
Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Articles
Challenges with real-world evidence to support HTA

Challenges with real-world evidence to support HTA

Tarang Sharma, expert in health economics and HTA, speaks with pharmaphorum on the challenges associated with using real-world evidence in HTA decision making. The emerging need for real-world evidence in HTA decision making is becoming apparent as regulators seek reassurance that...

Articles
Celebrating 30 years of the Orphan Drug Act and NORD

Celebrating 30 years of the Orphan Drug Act and NORD

Peter L. Saltonstall shares the progress of rare disease patient advocate NORD over the last 30 years, including the introduction of the Orphan Drug Act. The year 2013 marks a dual anniversary of great significance to the rare disease community: on January 4, 1983, President...

Articles
How I became part of the Quantified Self movement

How I became part of the Quantified Self movement

Jim Dayton shares his personal views on the increase in keeping track of one’s own health data, known as the Quantified Self movement, by using medical devices and mhealth apps. I am part of the Quantified Self movement. Which means: I am a person who believes that tracking one’s own...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Market Access
Solution Spotlight: Acumetis Model Builder
Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Editor's Picks

  1. Boehringer forges $7bn alliance with China's SBP Group News
  2. Lilly partners with Hims & Hers on obesity drug sales
  3. UK women's health firm Theramex sold for around £2.2bn
  4. What do midterms mean for Trump's pharma and health agenda?
  5. NICE backs Keytruda/Padcev combo for bladder cancer

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more